KR920005967A - 순환계 질병치료와 미용약물 치료에 사용되는 성분물 - Google Patents
순환계 질병치료와 미용약물 치료에 사용되는 성분물 Download PDFInfo
- Publication number
- KR920005967A KR920005967A KR1019910016774A KR910016774A KR920005967A KR 920005967 A KR920005967 A KR 920005967A KR 1019910016774 A KR1019910016774 A KR 1019910016774A KR 910016774 A KR910016774 A KR 910016774A KR 920005967 A KR920005967 A KR 920005967A
- Authority
- KR
- South Korea
- Prior art keywords
- component
- venous
- treat
- ingredient
- factor
- Prior art date
Links
- 239000004615 ingredient Substances 0.000 title claims 4
- 230000003796 beauty Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000002483 medication Methods 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 3
- 229920002674 hyaluronan Polymers 0.000 claims 3
- 229960003160 hyaluronic acid Drugs 0.000 claims 3
- 229940067606 lecithin Drugs 0.000 claims 3
- 235000010445 lecithin Nutrition 0.000 claims 3
- 239000000787 lecithin Substances 0.000 claims 3
- 102000016942 Elastin Human genes 0.000 claims 2
- 108010014258 Elastin Proteins 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 229920002549 elastin Polymers 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 206010057254 Connective tissue inflammation Diseases 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 208000000558 Varicose Ulcer Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000008081 blood perfusion Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000008406 cosmetic ingredient Substances 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 238000010606 normalization Methods 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000001297 phlebitis Diseases 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 238000004448 titration Methods 0.000 claims 1
- 230000024883 vasodilation Effects 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 치료용 또는 미용의 목적으로 사용되는 성분물로써 활성 히드로케네이트 레시틴, 히알루톤산, 엘라스틴과 함께 액상성분물의 용해제, 통상적인 부형제, 기초제가 포함된 것을 특징으로 하는 성분물.
- 제1항에 있어서, 다이아키시스인자가 첨가된 것을 특징으로 하는 치료용 또는 미용에 이용되는 성분물.
- 제1항에 있어서, 활성 성분물의 중량 퍼센트비가 다음과 같은 것을 특징으로 하는 성분물 : 히드로게네이트 레시틴 0.17-1.2W% 히알루톤산 0.47-1.2W% 엘라스틴 0.47-1.2W%.
- 제2항에 있어서, 다이아키시스인자 60 내지 70중량%비로 첨가된 것을 특징으로 하는 성분물.
- 제1,2,3 또는 4항에 있어서, 히드로게네이트 레시틴 3.5mg 히알루톤산 2.0mg 앨러수탄 2.0mg 다이아키시스인자 294mg 만니톨 120mg 증류수 적정량와 같은 제제형으로 구성된 것을 특징으로 하는 치료용 또는 미용성분물.
- 제1,2,3,4 또는 5항에 있어서, 정맥노장 정맥, 정맥염, 수종, 정맥노장으로 인한 궤양, 경화증 치료로 인한 정맥차단, 혈액관류의 정상화 치료에 사용되는 성분물.
- 제1,2,3,4,5 또는 6항에 있어서, 말초맥관확장증 코, 수족과 안면의 피하소성 결합조직염증, 조직이완증의 치료에 사용되는 것을 특징으로 하는 성분물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT02160690A IT1243734B (it) | 1990-09-28 | 1990-09-28 | Composizione per uso terapeutico e/o cosmetico per il trattamento di disturbi circolatori e per trattamenti di medicina estetica |
| IT21606A/90 | 1990-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR920005967A true KR920005967A (ko) | 1992-04-27 |
Family
ID=11184242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910016774A KR920005967A (ko) | 1990-09-28 | 1991-09-26 | 순환계 질병치료와 미용약물 치료에 사용되는 성분물 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0477833A1 (ko) |
| KR (1) | KR920005967A (ko) |
| IT (1) | IT1243734B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
| US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
| FR2758458B1 (fr) * | 1997-01-21 | 2000-01-07 | Jean Noel Thorel | Produits cosmetiques ou dermo-pharmaceutiques respectant l'ecologie cutanee |
| EP1987812A1 (de) * | 2007-04-23 | 2008-11-05 | Fibona Health Products GmbH | Tagesrhytmisch angepasste Anwendung von Hyaferm bei Cellulite |
| IT1393547B1 (it) * | 2009-04-01 | 2012-04-27 | Salati | Composizione cosmetica ad attivita' idratante e favorente l'elesticita' della pelle |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2356427A2 (fr) * | 1976-07-02 | 1978-01-27 | Ana Laboratoires | Nouveaux medicaments pour le traitement des surcharges lipidiques et de la cellulite |
| GB8613811D0 (en) * | 1986-06-06 | 1986-07-09 | Phares Pharm Res Nv | Composition & method |
| JP2554880B2 (ja) * | 1987-05-07 | 1996-11-20 | ポーラ化成工業株式会社 | 皮膚化粧料 |
-
1990
- 1990-09-28 IT IT02160690A patent/IT1243734B/it active IP Right Grant
-
1991
- 1991-09-24 EP EP91116188A patent/EP0477833A1/en not_active Withdrawn
- 1991-09-26 KR KR1019910016774A patent/KR920005967A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0477833A1 (en) | 1992-04-01 |
| IT9021606A1 (it) | 1992-03-28 |
| IT1243734B (it) | 1994-06-21 |
| IT9021606A0 (it) | 1990-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3549770A (en) | Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects | |
| NO891379D0 (no) | Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav. | |
| CN104667335A (zh) | 皮肤屏障功能或痔的重组人源胶原蛋白产品及制备方法 | |
| US4025645A (en) | Non-steroid topical agent for alleviating inflammation in mammals | |
| US4678668A (en) | Method of reducing soft tissue swelling and pain | |
| US7189406B1 (en) | Composition and method for treating skin | |
| KR100673044B1 (ko) | 경피 투여용 국소 조성물 | |
| Ohkuma | Molluscum contagiosum treated with iodine solution and salicylic acid plaster | |
| DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
| US5268176A (en) | Method and compositions for the non-invasive treatment of telangiectasia | |
| Webster | Common skin disorders in the elderly | |
| KR910005858A (ko) | 지방산 요법 | |
| KR920005967A (ko) | 순환계 질병치료와 미용약물 치료에 사용되는 성분물 | |
| US6399108B1 (en) | Compositions and methods for the treatment of skin disorders | |
| US7714015B2 (en) | Method and composition for treating sunburned skin | |
| US3200037A (en) | Topic angiotonic compositions | |
| DE69921678D1 (de) | Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen | |
| Carlson et al. | PGE1 in lschaemic Peripheral Vascular Disease | |
| Groel | Dimethyl Sulfoxide as a Vehicle for Corticosteroids: A Comparison With the Occlusive Dressing Technique | |
| US4150119A (en) | Method for treatment of vascular disease | |
| Linnitt | Skin management in lymphoedema | |
| RU98103858A (ru) | Препарат для лечения длительно незаживающих инфицированных язв и ран | |
| TWI325324B (ko) | ||
| JP2004262772A (ja) | グリチルリチン含有経皮製剤 | |
| BR102019009943A2 (pt) | formulação cosmética para cuidados da saúde dos pés e uso da mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19910926 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |